Warnings and Precautions
- As with any eye drop, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle to prevent contaminating the tip and solution. Keep bottle tightly closed when not in use
- Patients should not wear a contact lens if their eye is red. PAZEO® Solution should not be used to treat contact lens-related irritation. The preservative in PAZEO® Solution, benzalkonium chloride, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least five minutes after instilling PAZEO® Solution before they insert their contact lenses
Adverse Reactions
A total of 499 subjects participated in the phase III clinical safety trial involving treatment for 6 weeks, of which 330 were treated with PAZEO® Solution.1
The most commonly reported adverse reactions, occurring in 2% to 5% of patients treated with either PAZEO® Solution or vehicle:
- Blurred vision, dry eye, superficial punctate keratitis, dysgeusia, and abnormal sensation in eye1